SPARC, a matricellular protein: At the crossroads of cell-matrix communication (Matrix Biology (2000) 569-580) PII: S0945053X00001050

Matrix Biology

Volumn 19, Issue 8, 2001, Pages 815-827

  Brekken, R A ^a   Sage, E H ^a  

^a HOPE HEART INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERRATUM; ERROR; PRIORITY JOURNAL;

EID: 0035130880     PISSN: 0945053X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0945-053X(00)00133-5     Document Type: Erratum

References (85)

1. Testican a multidomain testicular proteoglycan resembling modulators of cell social behaviour
2. Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1
3. Osteonectin/SPARC is a product of articular chondrocytes/cartilage and is regulated by cytokines and growth factors
4. Chromosomal localization of the mouse homolog of the Huntington's disease linked G8 (D4S10) marker
5. Regulation of SPARC expression during early Xenopus development: evolutionary divergence and conservation of DNA regulatory elements between amphibians and mammals
6. Basic fibroblast growth factor destabilizes osteonectin mRNA in osteoblasts
7. Contributions of the I and EF hand domains to the divalent cation-dependent collagen binding activity of the alpha2beta1 integrin
8. Markers of complement-dependent and complement-independent glomerular visceral epithelial cell injury in vivo. Expression of antiadhesive proteins and cytoskeletal changes
9. Visceral glomerular epithelial cells can proliferate in vivo and synthesize platelet-derived growth factor B-chain
10. SPARC regulates the expression of collagen type I and transforming growth factor-beta1 in mesangial cells
11. Differential effects of SPARC and cationic SPARC peptides on DNA synthesis by endothelial cells and fibroblasts
12. SPARC/osteonectin induces matrix metalloproteinase 2 activation in human breast cancer cell lines
13. Mice deficient for the secreted glycoprotein SPARC/osteonectin/BM40 develop normally but show severe age-onset cataract formation and disruption of the lens
14. Cloning from purified high endothelial venule cells of hevina close relative of the antiadhesive extracellular matrix protein SPARC
15. Modulation of endothelial cell adhesion by hevinan acidic protein associated with high endothelial venules
16. Mapping of the binding of platelet-derived growth factor to distinct domains of the basement membrane proteins BM-40 and perlecan and distinction from the BM-40 collagen-binding epitope
17. SPARC (secreted protein acidic and rich in cysteine) regulates endothelial cell shape and barrier function
18. Increased SPARC expression promotes U87 glioblastoma invasion in vitro
19. Cell cycle-dependent nuclear location of the matricellular protein SPARC: association with the nuclear matrix
20. Transcription of a quail gene expressed in embryonic retinal cells is shut off sharply at hatching
21. SPARC antagonizes the effect of basic fibroblast growth factor on the migration of bovine aortic endothelial cells
22. Structure of a novel extracellular Ca(2+)-binding module in BM-40
23. Crystal structure of a pair of follistatin-like and EF-hand calcium-binding domains in BM-40
24. In vivo expression of mRNA for the Ca2+-binding protein SPARC (osteonectin) revealed by in situ hybridization
25. Expression and structure of human SPARC transcripts: SPARC mRNA is expressed by human cells involved in extracellular matrix production and some of these cells show an unusual expression pattern
26. On global sequence alignment
27. Expression of SPARC during development of the chicken chorioallantoic membrane: evidence for regulated proteolysis in vivo
28. Type I collagen-deficient Mov-13 mice do not retain SPARC in the extracellular matrix: implications for fibroblast function
29. Osteonectin promotes prostate cancer cell migration and invasion: a possible mechanism for metastasis to bone
30. Osteonectin in matrix remodeling. A plasminogen-osteonectin-collagen complex
31. Rat embryo fibroblasts transformed by c-Jun display highly metastatic and angiogenic activities in vivo and deregulate gene expression of both angiogenic and antiangiogenic factors
32. SPARC (BM-40 osteonectin) inhibits the mitogenic effect of vascular endothelial growth factor on microvascular endothelial cells
33. Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density and a bleeding diathesis
34. The biology of SPARC a protein that modulates cell-matrix interactions
35. SPARC is a source of copper-binding peptides that stimulate angiogenesis
36. The expression of the secreted protein acidic and rich in cysteine (SPARC) is associated with the neoplastic progression of human melanoma
37. Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells
38. Developmental and transformation-sensitive expression of the SPARC gene on mouse chromosome 11
39. Osteonectin expression correlates with clinical outcome in thin cutaneous malignant melanomas
40. Remodelling of cardiac extracellular matrix during beta-adrenergic stimulation: upregulation of SPARC in the myocardium of adult rats
41. High-affinity and low-affinity calcium binding and stability of the multidomain extracellular 40-kDa basement membrane glycoprotein (BM-40/SPARC/osteonectin)
42. Structural and functional characterization of the extracellular calcium-binding protein BM-40/secreted protein, acidic rich in cysteine/osteonectin from the nematode Caenorhabditis elegans
43. SC1: a marker for astrocytes in the adult rodent brain is upregulated during reactive astrocytosis
44. Extracellular matrix-associated protein Sc1 is not essential for mouse development
45. Characterization of the mouse SPARC/osteonectin gene. Intron/exon organization and an unusual promoter region
46. SPARC and thrombospondin genes are repressed by the c-jun oncogene in rat embryo fibroblasts
47. SPARC an extracellular matrix protein with tumor-suppressing activity in human ovarian epithelial cells
48. SPARC inhibits endothelial cell adhesion but not proliferation through a tyrosine phosphorylation-dependent pathway
49. Morphological and biochemical studies of a mouse mutant (fro/fro) with bone fragility
50. Enhancement of SPARC (osteonectin) synthesis in arthritic cartilage. Increased levels in synovial fluids from patients with rheumatoid arthritis and regulation by growth factors and cytokines in chondrocyte cultures
51. Heat-shock response in cultured chick embryo chondrocytes. Osteonectin is a secreted heat-shock protein
52. Developmental expression of 2ar (osteopontin) and SPARC (osteonectin) RNA as revealed by in situ hybridization
53. Evidence for positive and negative regulatory elements in the 5′-flanking sequence of the mouse sparc (osteonectin) gene
54. SPARC deficiency leads to early-onset cataractogenesis
55. SPARC is expressed by mesangial cells in experimental mesangial proliferative nephritis and inhibits platelet-derived-growth-factor-medicated mesangial cell proliferation in vitro
56. Distribution of SPARC in normal and neoplastic human tissue
57. Developmental anomalies of Xenopus embryos following microinjection of SPARC antibodies
58. The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors
59. SPARC and the extracellular matrix: implications for cancer and wound repair
60. SPARC: a signal of astrocytic neoplastic transformation and reactive response in human primary and xenograft gliomas
61. SPARC: a potential diagnostic marker of invasive meningiomas
62. Differential modulation of cell adhesion by interaction between adhesive and counter-adhesive proteins: characterization of the binding of vitronectin to osteonectin (BM40 SPARC)
63. Inhibition of endothelial cell proliferation by SPARC is mediated through a Ca(2+)-binding EF-hand sequence
64. Distribution of the calcium-binding protein SPARC in tissues of embryonic and adult mice
65. A physical map of 15 loci on human chromosome 5q23-q33 by two-color fluorescence in situ hybridization
66. Limited cleavage of extracellular matrix protein BM-40 by matrix metalloproteinases increases its affinity for collagens
67. Crystal structure and mapping by site-directed mutagenesis of the collagen-binding epitope of an activated form of BM-40/SPARC/osteonectin
68. Immunochemical and tissue analysis of protease generated neoepitopes of BM-40 (osteonectin SPARC) which are correlated to a higher affinity binding to collagens
69. Lead inhibits secretion of osteonectin/SPARC without significantly altering collagen or Hsp47 production in osteoblast-like ROS 17/2.8 cells
70. The Caenorhabditis elegans homologue of the extracellular calcium binding protein SPARC/osteonectin affects nematode body morphology and mobility
71. Extracellular calcium-binding protein SPARC/osteonectin in Caenorhabditis elegans
72. Effects of basic fibroblast growth factor on proliferation, the expression of osteonectin (SPARC) and alkaline phosphatase and calcification in cultures of human pulp cells
73. Differential effects of various growth factors and cytokines on the syntheses of DNA, type I collagen, laminin, fibronectin, osteonectin/secreted protein, acidic and rich in cysteine (SPARC) and alkaline phosphatase by human pulp cells in culture
74. Cloning from a mouse osteoblastic cell line of a set of transforming-growth-factor-beta 1-regulated genes one of which seems to encode a follistatin-related polypeptide
75. Cloning and expression of murine SC1 a gene product homologous to SPARC
76. Molecular analysis of the cDNA for human SPARC/osteonectin/BM-40: sequence, expression and localization of the gene to chromosome 5q31-q33
77. Osteonectin a bone-specific protein linking mineral to collagen
78. SPARC, a secreted protein associated with morphogenesis and tissue remodeling induces expression of metalloproteinases in fibroblasts through a novel extracellular matrix-dependent pathway
79. Osteogenesis imperfecta: changes in noncollagenous proteins in bone
80. Regulation of Smad activity
81. Regulation of the expression of a secreted acidic protein rich in cysteine (SPARC) in human fibroblasts by transforming growth factor beta. Comparison of transcriptional and post-transcriptional control with fibronectin and type I collagen
82. SPARC a matricellular glycoprotein with important biological functions
83. Specific interaction of SPARC with endothelial cells is mediated through a carboxyl-terminal sequence containing a calcium-binding EF hand
84. The counteradhesive protein SPARC regulates an endothelial paracellular pathway through protein tyrosine phosphorylation